Skip to main content

Advertisement

SpringerLink
Log in

Self-Limited Sepsis Syndrome Following Fecal Microbiota Therapy for Refractory C. difficile Infection

  • Stanford Multidisciplinary Seminars
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. NEJM. 2015;372:825–834.

    Article  CAS  PubMed  Google Scholar 

  2. Beran V, Chmelar D, Vobejdova J, et al. Sensitivity to antibiotics of Clostridium difficile toxigenic nosocomial strains. Folia Microbiol. 2014;59:209–215.

    Article  CAS  Google Scholar 

  3. Neal MD, Alverdy JC, Hall DE, et al. Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe complicated Clostridium difficile associated disease. Ann Surg. 2011;254:423–427.

    Article  PubMed  Google Scholar 

  4. Zainah H, Hassan M, Sheikh-Sroujieh L, et al. Intestinal microbiota transplantation, a simple and effective treatment for severe and refractory Clostridium difficile infection. Dig Dis Sci. 2015;60:181–185.

    Article  PubMed  Google Scholar 

  5. van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. NEJM. 2013;368:407–415.

    Article  PubMed  Google Scholar 

  6. Quera R, Espinoza R, Estay C, et al. Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn’s disease and recurrent Clostridium difficile infection. J Crohn’s Colitis. 2014;8:252–253.

    Article  Google Scholar 

  7. Kelly CR, Ihunnah C, Monika Fischer, et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol. 2014;109:1065–1071.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA

    Sundeep Singh

  2. Walnut Creek, CA, USA

    Emily Jing

  3. Division of Gastroenterology, University of California-San Francisco, San Francisco, CA, USA

    Neil Stollman

Authors
  1. Sundeep Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emily Jing
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Neil Stollman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Neil Stollman.

Ethics declarations

Conflict of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Singh, S., Jing, E. & Stollman, N. Self-Limited Sepsis Syndrome Following Fecal Microbiota Therapy for Refractory C. difficile Infection. Dig Dis Sci 61, 2488–2491 (2016). https://doi.org/10.1007/s10620-015-3955-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-015-3955-7

Keywords

Search

Navigation